Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
116,964,738
-
Total 13F shares
-
46,927,893
-
Share change
-
+6,781,648
-
Total reported value
-
$626,702,945
-
Put/Call ratio
-
79%
-
Price per share
-
$13.35
-
Number of holders
-
90
-
Value change
-
+$87,202,617
-
Number of buys
-
48
-
Number of sells
-
45
Institutional Holders of Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (CHRS) as of Q3 2017
As of 30 Sep 2017 Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (CHRS) had 90 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 46,927,893 shares of stock of the company.
Largest 10 holders included FMR LLC, Temasek Holdings (Private) Ltd, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., Kohlberg Kravis Roberts & Co. L.P., VANGUARD GROUP INC, STATE STREET CORP, JPMORGAN CHASE & CO, UBS ASSET MANAGEMENT AMERICAS INC, and PRICE T ROWE ASSOCIATES INC /MD/.
This table shows 90 institutional shareholders of the security as of 30 Sep 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.